Martin I, Shastri V P, Padera R F, Yang J, Mackay A J, Langer R, Vunjak-Novakovic G, Freed L E
Division of Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
J Biomed Mater Res. 2001 May;55(2):229-35. doi: 10.1002/1097-4636(200105)55:2<229::aid-jbm1009>3.0.co;2-q.
Bone marrow stromal cells (BMSC) are pluripotent progenitor cells that can regenerate different skeletal tissues in response to environmental signals. In this study, we used highly porous, structurally stable three-dimensional polymer foams in conjunction with specific regulatory molecules to selectively differentiate mammalian BMSC into either cartilaginous or bone-like tissues. Bovine BMSC were expanded in monolayers and cultured on 5-mm-diameter, 2-mm-thick foams made of poly(lactic-co-glycolic acid) and poly(ethylene glycol). Constructs maintained their original size and shape for up to 4 weeks of culture and supported BMSC growth and production of extracellular matrix (ECM). By proper use of chondrogenic (dexamethasone, insulin, transforming growth factor-beta1) or osteogenic (dexamethasone, beta-glycerophosphate) medium supplements, we could control whether the generated ECM was cartilaginous (containing collagen type II and sulfated glycosaminoglycans) or bone-like (containing osteocalcin, osteonectin, and mineralized foci). After 4 weeks of cultivation, cartilaginous and bone-like ECM were uniformly distributed throughout the construct volume and respectively represented 34.2 +/- 9.3% and 12.6 +/- 3.2% of the total available area. BMSC culture on poly(lactic-co-glycolic acid)/poly(ethylene glycol) foams provides a three-dimensional model system to study the development of mesenchymal tissues in vitro and has potential applications in engineering autologous grafts for skeletal tissue repair.
骨髓基质细胞(BMSC)是多能祖细胞,能够根据环境信号再生不同的骨骼组织。在本研究中,我们使用高度多孔、结构稳定的三维聚合物泡沫,并结合特定的调节分子,将哺乳动物BMSC选择性地分化为软骨样或骨样组织。牛BMSC在单层中扩增,并在由聚(乳酸-共-乙醇酸)和聚(乙二醇)制成的直径5毫米、厚2毫米的泡沫上培养。构建体在培养长达4周的时间内保持其原始大小和形状,并支持BMSC生长和细胞外基质(ECM)的产生。通过适当使用软骨生成(地塞米松、胰岛素、转化生长因子-β1)或成骨(地塞米松、β-甘油磷酸)培养基补充剂,我们可以控制生成的ECM是软骨样(含有II型胶原蛋白和硫酸化糖胺聚糖)还是骨样(含有骨钙素、骨连接蛋白和矿化灶)。培养4周后,软骨样和骨样ECM均匀分布在整个构建体体积中,分别占总可用面积的34.2±9.3%和12.6±3.2%。在聚(乳酸-共-乙醇酸)/聚(乙二醇)泡沫上培养BMSC提供了一个三维模型系统,用于体外研究间充质组织的发育,并在工程自体移植物用于骨骼组织修复方面具有潜在应用。